Curiously, apoE has recently been shown to affect AD pathology through its immunomodulatory function which is thought to be associated with its binding to microglial triggering receptor expressed on myeloid cells 2 (TREM2; reviewed in Ref. Here, APOE is linked to Alzheimer disease.